B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CHRM3

MOLECULAR TARGET

cholinergic receptor muscarinic 3

UniProt: P20309NCBI Gene: 113139 compounds

CHRM3 (cholinergic receptor muscarinic 3) is targeted by 39 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CHRM3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Hyoscyamine4.2066
2N-Methylscopolamine3.7843
3Arecoline3.7441
4Pilocarpine2.8917
5Scopolamine2.309
6Muscarine1.795
7Hyoscyamine1.614
8Ipratropium1.614
9Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent1.393
10Quetiapine Fumarate1.102
11hexahydrosiladiphenidol1.102
12Strychnine1.102
13Tolterodine Tartrate1.102
14Fluoxetine0.691
15Mianserin0.691
16Amoxapine0.691
17Astemizole Antihistamine drug now withdrawn from0.691
18Benzethonium Bactericidal cationic quaternary ammonium surfactant used as0.691
19Butaclamol0.691
20Chlorhexidine0.691
21Cyclacillin0.691
22Cyproheptadine0.691
23dilazep0.691
24Dimethindene0.691
25Fentanyl0.691
26Fluspirilene0.691
27Loxapine0.691
28Maprotiline0.691
29Metergoline0.691
30Nefopam Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for0.691
31Nortriptyline0.691
32oxatomide [Supplementary Concept] structure;0.691
33Promethazine0.691
34protriptyline0.691
35Tilorone0.691
36Tiotropium Bromide0.691
37Valproic Acid0.691
38Vemurafenib0.691
39Vincamine0.691

About CHRM3 as a Drug Target

CHRM3 (cholinergic receptor muscarinic 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 39 compounds with documented CHRM3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CHRM3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.